Moonwalk Biosciences Raises $70M Series B for Adipose-Targeted RNAi
Moonwalk Biosciences raised an oversubscribed $70 million Series B to advance adipose-targeted RNAi medicines for obesity and cardiometabolic disease.
Startup Funding Guides & Investor Research
Raising startup funding requires matching your stage, traction, and sector to the right investors. Our startup funding resources cover everything from first checks to growth rounds — with actionable guidance for founders navigating today's market.
Startup Funding Essentials
- Stage alignment: Seed, Series A, and growth investors have different risk and return profiles
- Investor targeting: Thesis fit, portfolio overlap, and check-size compatibility
- Fundraising process: Decks, data rooms, diligence, and term negotiation
- Market timing: When to raise, how much to raise, and runway planning
Explore startup funding articles to sharpen your raise and find investors who fit your company.
Related Articles (817 articles)
-
-
Celero Communications Raises $275M at a $3B+ Valuation
Celero Communications raised a $275 million Series C, bringing total capital raised to $415 million and valuing the AI optical-interconnect company above $3 billion.
-
September 8–9 Investment News: Cognition $48B, Space Reuse Megarounds, Forus $3B
Grouped coverage of Cognition’s $2B Series E at $48B, Stoke’s $1B Series E, The Exploration Company’s $450M Series C, Forus’s $150M at $3B, and Sapien’s $180M valuation round — plus Mistral on the September 8 index and recycled aggregator tape.
-
CloudNC’s $20M B Extension: Four Years After Autodesk, $128M Lifetime Does Not Add
Nimble Ventures led a $20 million Series B extension for London CNC software company CloudNC, reported September 8, 2026. The last major print was a $45 million Autodesk-led Series B in June 2022 (~$78 million lifetime then). The CEO told TechCrunch lifetime capital is now $128 million. Valuation was not disclosed.
-
Cognition’s $2B Series E at $48B: a16z and Accel Double Down After Cursor’s Exit
Devin maker Cognition closed more than $2B at $48B — nearly doubling May’s $26B mark — as company-stated run-rate climbed from $492M to almost $900M in four months.
-
The Exploration Company’s $450M Series C: Atomico, EQT Scaleup, and Bessemer Bet on European Reuse
TEC closed $450M Series C — billed as Europe’s largest space Series C — co-led by Atomico and EQT’s Scaleup Europe Fund with Bessemer, citing >$2B in contracts and a 2028 ISS docking target for Nyx.